Andrew T Drechsler Insider Trading
Get free email notifications about insider trading for Andrew T Drechsler.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Andrew T Drechsler. Andrew T Drechsler is a Chief Financial Officer in INSMED Inc ($INSM) and a Chief Financial Officer in Valera Pharmaceuticals Inc ($VLRX) and a Chief Financial Officer in Provention Bio, Inc. ($PRVB) and a Director in Baudax Bio, Inc. ($BXRX).
Address: C/O VALERA PHARMACEUTICALS, INC. 7 CLARKE DRIVE CRANBURY 08512-3617 NJ
Companies in which Andrew T Drechsler is an Insider
Baudax Bio, Inc.
Trading Symbol: BXRXIndustry: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
Position of Andrew T Drechsler: Director
Holdings: 76,452 shares
Latest Transaction: Apr 08 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
INSMED Inc
Trading Symbol: INSMIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Andrew T Drechsler: Chief Financial Officer
Holdings: 5,000 shares
Current Value: $77,450
Latest Transaction: Nov 18 2016
$INSM Market Capitalization: $931.87M
$INSM Previous Close: $15.49
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Provention Bio, Inc.
Trading Symbol: PRVBIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Andrew T Drechsler: Chief Financial Officer
Holdings: 20,000 shares
Latest Transaction: May 14 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Valera Pharmaceuticals Inc
Trading Symbol: VLRXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Andrew T Drechsler: Chief Financial Officer
Holdings: 0 shares
Latest Transaction: Apr 18 2007
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Andrew T Drechsler
Sentiment: All, BXRX, INSM, PRVB, VLRX
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 14 2021 | PRVB | Provention Bio, In ... | Drechsler Andrew T | Chief Financial Off ... | Option Exercise | A | 6.80 | 139,500 | 948,600 | 139,500 | |
Apr 08 2021 | BXRX | Baudax Bio, Inc. | Drechsler Andrew T | Director | Option Exercise | A | 1.24 | 83,333 | 103,333 | 83,333 | |
Apr 08 2021 | BXRX | Baudax Bio, Inc. | Drechsler Andrew T | Director | Grant | A | 0.00 | 56,452 | 0 | 76,452 | 20 K to 76.5 K (+282.26 %) |
Sep 02 2020 | PRVB | Provention Bio, In ... | Drechsler Andrew T | Chief Financial Off ... | Buy | P | 11.72 | 2,000 | 23,440 | 20,000 | 18 K to 20 K (+11.11 %) |
Aug 21 2020 | BXRX | Baudax Bio, Inc. | Drechsler Andrew T | Director | Grant | A | 0.00 | 20,000 | 0 | 20,000 | 0 to 20 K |
Aug 13 2020 | PRVB | Provention Bio, In ... | Drechsler Andrew T | Chief Financial Off ... | Buy | P | 13.01 | 1,750 | 22,768 | 18,000 | 16.3 K to 18 K (+10.77 %) |
Jul 16 2020 | PRVB | Provention Bio, In ... | Drechsler Andrew T | Chief Financial Off ... | Option Exercise | A | 12.62 | 137,750 | 1,738,405 | 137,750 |